openPR Logo
Press release

Human Microbiome Sequencing Technology Market to Witness Strong Growth by 2028 | Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., Clinical Microbiomics A/S

07-14-2022 01:35 PM CET | Health & Medicine

Press release from: ReportsnReports

Human Microbiome Sequencing Technology Market research report contains a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies interspersed with relevant data. Furthermore, the report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. It also examines market performance and the market position during the forecast period.

Click Here For Free Sample + Related Graphs of the Report at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=5954741

Human Microbiome Sequencing Technology Market research report presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing crucial parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

The key players covered in this Human Microbiome Sequencing Technology Market report:

- Baseclear B.V.
- Beijing Genomics Institute (BGI) Genomics Co., Ltd
- Charles River Laboratories International Inc.
- Clinical Microbiomics A/S
- Eurofins Scientific SE
- GENEWIZ, Inc.
- Illumina, Inc.
- Novogene Corporation
- OraSure Technologies, Inc.
- Oxford Nanopore Technologies, Inc.
- Pacific Biosciences of California, Inc.
- QIAGEN N.V.
- Second Genome, Inc.
- Thermo Fisher Scientific Inc.
- Viome, Inc.
- CosmosID
- Leucine Rich Bio Pvt. Ltd.
- Microba
- Microbiome Insights Inc.
- Molzym GmbH & Co. KG

As the global economy mends, the 2021 growth of Human Microbiome Sequencing Technology will have significant change from previous year. According to our latest study, the global Human Microbiome Sequencing Technology market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Human Microbiome Sequencing Technology market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Human Microbiome Sequencing Technology market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Microbiome Sequencing Technology market, reaching US$ million by the year 2028. As for the Europe Human Microbiome Sequencing Technology landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Human Microbiome Sequencing Technology players cover Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., and Clinical Microbiomics A/S, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Microbiome Sequencing Technology market by product type, application, key players and key regions and countries.

Segmentation by type:

- Traditional Sequencing Technologies
- Next-Generation Sequencing
- Third Generation Sequencing

Segmentation by application:

- Research and Academic Institutions
- Pharmaceutical and Biotechnology Companies
- Hospital and Clinic
- Others

This report also splits the market by region:

- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries

Purchase This Report (FLAT 30% Discount): https://www.reportsnreports.com/purchase.aspx?name=5954741

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Microbiome Sequencing Technology Market Size 2017-2028
2.1.2 Human Microbiome Sequencing Technology Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Human Microbiome Sequencing Technology Segment by Type
2.2.1 Traditional Sequencing Technologies
2.2.2 Next-Generation Sequencing
2.2.3 Third Generation Sequencing
2.3 Human Microbiome Sequencing Technology Market Size by Type
2.3.1 Human Microbiome Sequencing Technology Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Human Microbiome Sequencing Technology Market Size Market Share by Type (2017-2022)
2.4 Human Microbiome Sequencing Technology Segment by Application
2.4.1 Research and Academic Institutions
2.4.2 Pharmaceutical and Biotechnology Companies
2.4.3 Hospital and Clinic
2.4.4 Others
2.5 Human Microbiome Sequencing Technology Market Size by Application
2.5.1 Human Microbiome Sequencing Technology Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Human Microbiome Sequencing Technology Market Size Market Share by Application (2017-2022)
3 Human Microbiome Sequencing Technology Market Size by Player
3.1 Human Microbiome Sequencing Technology Market Size Market Share by Players
3.1.1 Global Human Microbiome Sequencing Technology Revenue by Players (2020-2022)
3.1.2 Global Human Microbiome Sequencing Technology Revenue Market Share by Players (2020-2022)
3.2 Global Human Microbiome Sequencing Technology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Human Microbiome Sequencing Technology by Regions
4.1 Human Microbiome Sequencing Technology Market Size by Regions (2017-2022)
4.2 Americas Human Microbiome Sequencing Technology Market Size Growth (2017-2022)
4.3 APAC Human Microbiome Sequencing Technology Market Size Growth (2017-2022)
4.4 Europe Human Microbiome Sequencing Technology Market Size Growth (2017-2022)
4.5 Middle East & Africa Human Microbiome Sequencing Technology Market Size Growth (2017-2022)
5 Americas
5.1 Americas Human Microbiome Sequencing Technology Market Size by Country (2017-2022)
5.2 Americas Human Microbiome Sequencing Technology Market Size by Type (2017-2022)
5.3 Americas Human Microbiome Sequencing Technology Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Microbiome Sequencing Technology Market Size by Region (2017-2022)
6.2 APAC Human Microbiome Sequencing Technology Market Size by Type (2017-2022)
6.3 APAC Human Microbiome Sequencing Technology Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Human Microbiome Sequencing Technology by Country (2017-2022)
7.2 Europe Human Microbiome Sequencing Technology Market Size by Type (2017-2022)
7.3 Europe Human Microbiome Sequencing Technology Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Microbiome Sequencing Technology by Region (2017-2022)
8.2 Middle East & Africa Human Microbiome Sequencing Technology Market Size by Type (2017-2022)
8.3 Middle East & Africa Human Microbiome Sequencing Technology Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Human Microbiome Sequencing Technology Market Forecast

Contact Us:

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Microbiome Sequencing Technology Market to Witness Strong Growth by 2028 | Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., Clinical Microbiomics A/S here

News-ID: 2680255 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Sequencing

Sequencing Reagents Market Report 2024 - Sequencing Reagents Market Trends And S …
"The Business Research Company recently released a comprehensive report on the Global Sequencing Reagents Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Sequencing the Future: Next Generation Sequencing Market Projections (2023-2033)
The global Next-generation Sequencing Market was over 8.5 billion in 2022 and it is anticipated to grow at a CAGR of over 18.2% during the forecast period. Market Outlook: The Next Generation Sequencing (NGS) market is set for an extraordinary trajectory of growth and innovation from 2023 to 2033. This decade is poised to witness a paradigm shift in genomics and molecular biology, with NGS technologies playing a central role in reshaping
Sequencing Reagents Market - Elevating Accuracy, Inspiring Discovery: Revolution …
Newark, New Castle, USA - new report, titled Sequencing Reagents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Sequencing Reagents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Sequencing Reagents market. The report offers an overview of the market, which
Microbiome Sequencing Services Market By Technology (Sequencing By Synthesis (SB …
Microbiome are the group of microorganisms that grow on saliva, skin layers, conjunctiva, oral mucosa and the gastrointestinal tract. Microbiome sequencing is the study and analysis of microbes groups located outside and inside of the human body to gain knowledge about human microbes. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00004419/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis: Baseclear B.V. Clinical-Microbiomics A/S Molzym GmbH & Co. Kg Zymo Research Corp. Rancho Biosciences Microbiome Therapeutics, LLC. Microbiome Insights Inc. Openbiome Resphera Biosciences, LLC. Ubiome, Inc. The report covers key developments
Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Search4Research.com Get Research Sample PDF at https://www.search4research.com/request-sample/113582/ Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,
Metagenomic Sequencing Market Technology Outlook 2027 - 16s Rrna Sequencing, Sho …
Worldwide Metagenomic Sequencing Market Analysis to 2027 is a specialized and in-depth study of the Metagenomic Sequencing Industry with a focus on the global market trend. The report aims to provide an overview of global Metagenomic Sequencing Market with detailed market segmentation by product/application and geography. The global Metagenomic Sequencing Market is expected to witness high growth during the forecast period. Metagenomics, is a field where genomic analysis of microbial DNA